These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 17634147

  • 1. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y, San-Marina S, Yang L, Khoury H, Minden MD.
    Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
    [Abstract] [Full Text] [Related]

  • 2. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N, Maor S, Sarfstein R, Abramovitch S, Welshons WV, Curran EM, Lee AV, Werner H.
    J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional activation of c-myc proto-oncogene by WT1 protein.
    Han Y, San-Marina S, Liu J, Minden MD.
    Oncogene; 2004 Sep 09; 23(41):6933-41. PubMed ID: 15286719
    [Abstract] [Full Text] [Related]

  • 4. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
    Fraizer G, Leahy R, Priyadarshini S, Graham K, Delacerda J, Diaz M.
    Int J Oncol; 2004 Mar 09; 24(3):461-71. PubMed ID: 14767530
    [Abstract] [Full Text] [Related]

  • 5. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X, Xing G, Saunders GF.
    Anticancer Res; 1999 Mar 09; 19(3A):1641-8. PubMed ID: 10470095
    [Abstract] [Full Text] [Related]

  • 6. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4].
    Shen HL, Chen ZX, Wang W, Cen JN, Hu SY, Zhao Y.
    Ai Zheng; 2006 Feb 09; 25(2):163-9. PubMed ID: 16480579
    [Abstract] [Full Text] [Related]

  • 7. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY, Qiu QQ, Huang J, Gurrieri M, Deuel TF.
    Oncogene; 1995 Feb 02; 10(3):415-22. PubMed ID: 7845666
    [Abstract] [Full Text] [Related]

  • 8. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor.
    Menke AL, Shvarts A, Riteco N, van Ham RC, van der Eb AJ, Jochemsen AG.
    Cancer Res; 1997 Apr 01; 57(7):1353-63. PubMed ID: 9102224
    [Abstract] [Full Text] [Related]

  • 9. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
    Menke AL, Riteco N, van Ham RC, de Bruyne C, Rauscher FJ, van der Eb AJ, Jochemsen AG.
    Oncogene; 1996 Feb 01; 12(3):537-46. PubMed ID: 8637710
    [Abstract] [Full Text] [Related]

  • 10. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R, Fraizer GC, Trapman J, Lau YfC, Saunders GF.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [Abstract] [Full Text] [Related]

  • 11. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM, Hinkes MT, Bernfield M, Rauscher FJ.
    Oncogene; 1996 Oct 17; 13(8):1789-99. PubMed ID: 8895526
    [Abstract] [Full Text] [Related]

  • 12. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep 17; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 13. The Wilms tumour suppressor protein WT1 (+KTS isoform) binds alpha-actinin 1 mRNA via its zinc-finger domain.
    Morrison AA, Venables JP, Dellaire G, Ladomery MR.
    Biochem Cell Biol; 2006 Oct 17; 84(5):789-98. PubMed ID: 17167543
    [Abstract] [Full Text] [Related]

  • 14. A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers.
    Little MH, Holmes G, Pell L, Caricasole A, Duarte A, Law M, Ward A, Wainwright B.
    Oncogene; 1996 Oct 03; 13(7):1461-9. PubMed ID: 8875984
    [Abstract] [Full Text] [Related]

  • 15. Functional properties of WT1.
    Haber DA, Englert C, Maheswaran S.
    Med Pediatr Oncol; 1996 Nov 03; 27(5):453-5. PubMed ID: 8827073
    [Abstract] [Full Text] [Related]

  • 16. Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells.
    Burwell EA, McCarty GP, Simpson LA, Thompson KA, Loeb DM.
    Oncogene; 2007 May 17; 26(23):3423-30. PubMed ID: 17160023
    [Abstract] [Full Text] [Related]

  • 17. New insights into DNA-binding behavior of Wilms tumor protein (WT1)--a dual study.
    Nurmemmedov E, Yengo RK, Uysal H, Karlsson R, Thunnissen MM.
    Biophys Chem; 2009 Dec 17; 145(2-3):116-25. PubMed ID: 19853363
    [Abstract] [Full Text] [Related]

  • 18. [Inhibition of proliferation in MCF-7 breast cancer cells by plasmid-based siRNA targeting to oncogene c-myc].
    Zhou CH, Peng XD, Wu J, Zhang P, Zhao ZR, Wei DP, Zhang CJ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May 17; 39(3):373-7. PubMed ID: 18575318
    [Abstract] [Full Text] [Related]

  • 19. The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells.
    Sarfstein R, Werner H.
    J Neurochem; 2006 Nov 17; 99(3):818-26. PubMed ID: 16911581
    [Abstract] [Full Text] [Related]

  • 20. Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene.
    Anant S, Axenovich SA, Madden SL, Rauscher FJ, Subramanian KN.
    Oncogene; 1994 Nov 17; 9(11):3113-26. PubMed ID: 7936634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.